NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2053220084

Registered date:02/09/2022

Exploratory study of IK-01 for knee osteoarthritis

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedOsteoarthritis of the knee
Date of first enrollment01/09/2022
Target sample size10
Countries of recruitment
Study typeInterventional
Intervention(s)IK-01 is transplanted or IK-01 is transplanted simultaneously with high tibial osteotomy in patients with knee osteoarthritis

Outcome(s)

Primary OutcomeChange from baseline in the WOMAC total score at 52 weeks post-transplantation
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 75age old
GenderBoth
Include criteria- Patients who have provided written informed consent using an IRB-approved explanation/consent form - Patients aged 20 to less than 75 years at the time of informed consent - Patients diagnosed with knee osteoarthritis according to the ACR classification criteria for knee osteoarthritis (clinical findings and X-ray imaging findings) during the screening period - Patients diagnosed with knee osteoarthritis of Kellgren-Lawrence grade 2 or 3 on standing frontal X-ray findings during the screening period
Exclude criteria- Patients have multiple arthropathies in the lower extremities - Patients with a history of or need to undergo surgery such as knee meniscectomy or suturing at the time of informed consent. However, if there is a history of meniscal resection or suturing, patients who have passed a certain period (8 weeks or more) after surgery can be enrolled - Patients with a history of or need surgery such as ligament reconstruction for ligament damage of the evaluation target knee at the time of informed consent. However, patients who have passed a certain period (8 weeks or more) after surgery can be enrolled - Patients who are judged to be inappropriate by the principal investigator or sub investigator

Related Information

Contact

Public contact
Name Regenerative medicine Products Development
Address 4th Floor, 9-6, Nibancho, Chiyoda Ku, Tokyo 102-0084, Japan Tokyo Japan 102-0084
Telephone +81-3-6457-9861
E-mail info@hirosaki-li.co.jp
Affiliation Hirosaki Lifescience Innovation, Inc.
Scientific contact
Name Koji Otsuka
Address 4th Floor, 9-6, Nibancho, Chiyoda Ku, Tokyo 102-0084, Japan Tokyo Japan 102-0084
Telephone +81-3-6457-9861
E-mail info@hirosaki-li.co.jp
Affiliation Hirosaki Lifescience Innovation, Inc.